The overactivation of NF‐κB in LSCs induces the expression of antiapoptotic genes, blocking LSC apoptosis and contributing to the persistence of AML, resulting in decreased treatment efficacy and increased relapse rates. The gene discussed is NFKB1; the disease is acute myeloid leukemia.